The Food and Drug Administration (FDA) abruptly canceled a vaccine advisory meeting where members were slated to discuss influenza vaccine strains. The meeting was scheduled for March 13.

An FDA vaccine advisory committee meeting to discuss next season’s flu vaccine has been canceled, potentially delaying the delivery schedule.

The meeting is the second federal vaccine panel meeting Trump administration officials have canceled or postponed since RFK Jr. took over HHS.

The reported cancellation is the second time a federal-level vaccination panel meeting has been affected since Robert F. Kennedy Jr took over as the Health and Human Services secretary.

The Food and Drug Administration Wednesday abruptly and unexpectedly cancelled a planned March 13 vaccine advisory committee meeting that was to have chosen the flu strains in next year's U.S. flu vaccine.

The Trump administration has canceled an upcoming meeting of the Food and Drug Administration’s vaccine advisory committee, a move that could complicate efforts to produce flu shots in time for the upcoming season.

A March meeting of outside advisers to the US Food and Drug Administration to discuss the composition of flu vaccines for this fall’s flu season has been canceled, a member of the advisory committee told CNN.

The advisory committee meeting is a critical resource for vaccine makers trying to figure out which flu strains to include in their shots for the next flu season.

This is the second cancellation to vaccine-related advisory panels since RFK Jr. took the helm at the Department of Health and Human Services.

Two long-planned vaccine meetings — one at the US Centers for Disease Control and another at the US Food and Drug Administration — have now been disrupted under the watch of US Health and Human Services Secretary Robert F.